Tempus ECG-AF vs Steth IO
AI Verdict
Choose Tempus ECG-AF if…
Choose Tempus ECG-AF if your primary goal is to proactively identify elderly patients (65+) within your clinic or hospital system who are at an elevated risk of developing new-onset atrial fibrillation within the next year. This tool is ideal for integrating into existing cardiology workflows to enhance early detection and enable timely preventative interventions or closer monitoring for a specific, at-risk population.
View Tempus ECG-AF →Choose Steth IO if…
Choose Steth IO if you require a versatile, portable solution for real-time auscultation, visualization, and sharing of heart and lung sounds, particularly in telemedicine or remote patient monitoring scenarios. This tool is best suited for clinicians needing to perform remote diagnostic assessments, collaborate with specialists by sharing recorded exams, or provide ongoing virtual care where physical examination is limited.
View Steth IO →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Tempus ECG-AF | Steth IO |
|---|---|---|
| Pricing | Contact vendor | Customized pricing; subscription-based for steth io spot. |
| Deployment | Software solution, integrated into healthcare facility systems with advanced cardiology algorithms. | Mobile app, Cloud-based system. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Steth IOSteth IO offers a highly intuitive, mobile-first experience by leveraging smartphones for real-time auscultation, visualization, and sharing. This direct interaction with a familiar device for data capture and immediate feedback likely provides a more user-friendly experience compared to Tempus ECG-AF's integration into existing, potentially complex, facility systems.
Clinical Value
Tempus ECG-AFTempus ECG-AF provides a unique predictive capability for early AF risk detection within 12 months, which can lead to proactive patient management and potentially prevent serious cardiac events. While Steth IO enhances diagnostic accuracy for auscultation, Tempus ECG-AF's ability to identify future risk for a specific, prevalent condition offers a distinct and high-impact clinical benefit.
Pricing & Value
Tempus ECG-AFTempus ECG-AF has a significant advantage with established CMS reimbursement codes (CPT 0764T and CPT 0765T to APC 5734, Medicare rate of $128.90), providing a clear financial pathway for healthcare facilities to adopt and utilize the technology. This direct reimbursement mechanism offers a more tangible and predictable value proposition compared to Steth IO's customized subscription model, which lacks specific service reimbursement codes.
Enterprise Readiness
Tempus ECG-AFTempus ECG-AF explicitly states HIPAA compliance and the availability of a Business Associate Agreement (BAA), along with integration into existing healthcare facility systems. In contrast, Steth IO's statement that the 'user responsible for compliance' regarding HIPAA poses a significant barrier for enterprise adoption, as organizations typically require vendor accountability for data security and privacy.
Innovation
Steth IOSteth IO demonstrates strong innovation by transforming a ubiquitous smartphone into an FDA-cleared diagnostic stethoscope with real-time visualization, recording, and telemedicine capabilities. This approach not only enhances a fundamental diagnostic process but also significantly expands access to advanced auscultation in remote and virtual care settings.
Support & Docs
Tempus ECG-AFTempus ECG-AF, as part of a larger AI and precision medicine company, offers a more extensive 'Document Library' and dedicated support team, which is crucial for enterprise-level deployment and ongoing clinical integration. Steth IO provides essential user documentation and direct support, but its resources appear more tailored to individual device usage rather than comprehensive enterprise needs.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Tempus ECG-AF | Steth IO |
|---|---|---|
| Product Name | Tempus ECG-AF | Steth IO |
| Company | Tempus AI, Inc. | STRATOSCIENTIFIC |
| Core Functionality | AI-based algorithm analyzing 12-lead ECG recordings to identify patients at increased risk of developing atrial fibrillation/flutter (AF) within 12 months. | Smartphone stethoscope for hearing, visualizing, recording, and sharing heart and lung sounds in real-time. |
| Primary Categories | Cardiology AI | Cardiology AI, Telehealth & Virtual Care, Wearables & Remote Monitoring (RPM) |
| Target Patient Population/Use Case | Patients aged 65 or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery, for earlier identification and follow-up of AF risk. | Healthcare providers for enhanced diagnostic accuracy, advanced telemedicine, and remote patient monitoring for comprehensive patient care. |
| Specialties | Cardiology, Geriatrics, Internal Medicine | Cardiology, Internal Medicine, Pulmonology |
Videos
Demos, reviews, and walkthroughs featuring Tempus ECG-AF and Steth IO.
Frequently Asked Questions
More Comparisons
More matchups featuring Tempus ECG-AF or Steth IO
Backers
Who funded each tool's parent company.